Regulation of FRTL-5 thyroid cell growth by phosphatidylinositol (OH) 3 kinase-dependent Akt-mediated signaling

Thyroid

Volumn 11, Issue 4, 2001, Pages 339-351

  Saito, J ^a,b   Kohn, A D ^c   Roth, R A ^c   Noguchi, Y ^b   Tatsumo, I ^b   Hirai, A ^b   Suuki, K ^a,d   Kohn, L D ^a   Saji, M ^d   Ringel, M D ^d,e  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b CHIBA UNIVERSITY   (Japan)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WASHINGTON HOSPITAL CENTER   (United States)

^e Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYCLIN A; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; DNA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P27; PROTEIN SERINE THREONINE KINASE; RETINOBLASTOMA PROTEIN; RNA; SOMATOMEDIN C; THYROTROPIN; WORTMANNIN;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; THYROID CELL;

EID: 0035011548     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/10507250152039073     Document Type: Article

References (56)

1. Receptors of the thyroid: The thyrotropin receptor is only the first violinist of a symphony orchestra
2. Transducing systems in the control of human thyroid cell function, proliferation and differentiation
3. Insulin and TSH promote growth in size of PC C13 rat thyroid cells, possibly via a pathway different from DNA synthesis
4. Repeatedly passed FRTL-5 rat thyroid cells can develop insulin and insulin-like growth factor-1-sensitive cyclooxygenase and prostaglandin E2 isomerase-like activities together with altered basal and thyrotropin-responsive thymidine incorporation into DNA
5. Regulation of prostaglandin synthesis by thyrotropin, insulin, or insulin-like growth factor-1, and serum in FRTL-5 rat thyroid cells
6. Cyclooxygenase-dependent thyroid cell proliferation induced by immunoglobulins from patients with Graves' disease
7. Geranylgeranylated Rho small GTPase(s) are essential for the degradation of p27kip1 and facilitate the progression for G1 to S phase in growth-stimulated rat FRTL-5 cells
8. Newly synthesized Rho A, not Ras, is isoprenylated and translocated to membranes coincident with progression of the G1 to S phase of growth-stimulated rat FRTL-5 cells
9. Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines
10. Somatostatin is expressed in FRTL-5 thyroid cells and prevents thyrotropin-mediated down-regulation of the cyclin-dependent kinase inhibitor p27kip1
11. Somatostatin interferes with thyrotropin-induced G1-S transition mediated by camp-dependent protein kinase and phosphatidylinositol 3-kinase. Involvement of RhoA and Cyclin E-cyclin-dependent kinase 2-complexes
12. Phosphoinositide 3-kinases: A conserved family of signal transducers
13. Phosphoinositide 3-kinase: A new effector in signal transduction?
14. Germline mutation in the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
15. Germline mutations in PTEN are present in Bannayan-Zonana syndrome
16. Phosphatidylinositol-3-OH kinase as a direct target of Ras
17. Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway
18. Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survival
19. Signalling pathways of insulin-like growth factor-1 that are augmented by cAMP in FRTL-5 cells
20. Phosphatidylinositol 3-kinase, protein kinase B and ribosomal S6 kinases in the stimulation of thyroid epithelial cell proliferation by cAMP and growth factors in the presence of insulin
21. Akt/protein kinase B promotes survival and hormone-independent proliferation of thyroid cells in the absence of dedifferentiating and transforming effects
22. Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily
23. The SH2-like Akt homology (AH) domain of c-akt is present in multiple copies in the genome of vertebrate and invertebrate eucaryotes. Cloning and characterization of the Drosophila melanogaster c-akt homolog Dakt1
24. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like domain
25. Akt2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas
26. Identification of a human Akt3 (Protein kinase B gamma) which contains the regulatory serine phosphorylation site
27. Akt activation by growth factors is a multiple-step process: The role of the PH domain
28. Protein kinase C zeta is a negative regulator of protein kinase B activity
29. Mechanism of activation of protein kinase B by insulin and IGF-1
30. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
31. Activation of Akt/Protein Kinase B by G protein-coupled receptors
32. Construction and characterization of a conditionally active version of the serine/threonine kinase akt
33. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
34. Regulation of neuronal survival by the serine-threonine protein kinase Akt
35. Antiapoptotic signaling by the Insulin-like growth factor I receptor, phosphatidyl-inositol 3-kinase, and Akt
36. Extracellular HIV-1 Tat protein activates phosphatidylinositol 3- and Akt/PKB kinases in CD4+ T lymphoblastoid Jurkat cells
37. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit
38. CREB is a regulatory target for the protein kinase Akt/PKB
39. The FRTL-5 thyroid cell strain as a model for studies on thyroid cell growth
40. Thyrotropin induces G1 cyclin expression and accelerates G1 phase after insulin-like growth factor I stimulation in FRTL-5 cells
41. Expression of a constitutively activated Akt ser/thr kinase in 3T3-L1 adipocytes stimulated glucose uptake and glucose transporter 4 translocation
42. Thyroid transcription factor-1 is calcium modulated and coordinately regulates genes involved in calcium homeostasis in C cells
43. Regulation of 3-hydroxy methylglutaryl coenzyme A reductase gene expression in FRTL5 cells II. down-regulation by v-k-ras oncogene
44. Cell cycle progression and 3-hydroxy-3-methylglutaryl coenzyme A reductase are regulated by thyrotropin in FRTL-5 rat thyroid cells
45. Insulin-like growth factor-1 stimulate the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves' IgG
46. Clinical Review 101: Thyrotropin may note be the dominant growth factor in benign and malignant thyroid tumors
47. Somatic and germline mutations of the TSH receptor gene in thyroid diseases
48. Oncogenic potential of guanine nucleotide stimulatory factor alpha subunit in thyroid glands of transgenic mice
49. Overexpression of the c-MET/HGF receptor in human thyroid carcinomas derived form the follicular epithelium
50. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary thyroid carcinomas
51. Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas
52. Fibroblast growth factors 1 and 2 and fibroblast growth factor receptor I are elevated in thyroid neoplasia
53. Expression of insulin-like growth factor receptors in primary human thyroid neoplasms
54. A refractory phase in cyclic-AMP responsive transcription requires down-regulation of protein kinase A
55. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas
56. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA